The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

SureCN27636     [(3R,7R,8S,8aS)-8-[2- [(2S,4S)-4-hydroxy-6...

Synonyms: AG-K-36165, CTK6C7487, AC1L7RH1, NCI60_011226
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

High impact information on Mevacor

  • When cells are pretreated with LOV, the ability of both FOH and GGOH to restore protein isoprenylation is time dependent; as the LOV pretreatment time increases, the time required for FOH and GGOH to restore isoprenylation also increases [1].
  • Treatment of NIH3T3 cells with lovastatin (LOV), an HMG-CoA reductase inhibitor, depletes cells of these derivatives and impairs isoprenylation of RAS and RAS-related proteins [1].
  • Over a 48-h time span, FOH is unable to maintain RAS isoprenylation in the continuing presence of LOV, whereas GGOH is able to maintain Rap1 isoprenylation in the presence of LOV at all times tested [1].
  • (4) In contrast, the increase in Lov and 25-HC sensitive cholesterol synthesis were higher in resting, but lower in stimulated HC monocytes than in control cells [2].
  • A, S, L and C were moderate inhibitors in both cellular systems of CYP3A4 [3].

References

  1. Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis. Ownby, S.E., Hohl, R.J. Lipids (2003) [Pubmed]
  2. Neuropeptides induced a pronounced and statin-sensitive dysregulation of mevalonate cycle in human monocytes of patients with hypercholesterolemia. Koszt??czky, B., F??ris, G., Seres, I., Balogh, Z., F??l??p, P., Koncsos, P., Paragh, G. Neuropeptides (2006) [Pubmed]
  3. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes. Cohen, L.H., van Leeuwen, R.E., van Thiel, G.C., van Pelt, J.F., Yap, S.H. Biopharmaceutics & drug disposition. (2000) [Pubmed]
 
WikiGenes - Universities